In vitro suceptibilities of clinical yeast isolates to the new antifungal eberconazole compared with their susceptibilities to clotrimazole and ketoconazole

J.M. Torres-Rodríguez; R. Méndez; O. López-Jodra; Y. Morera; M. Espasa; T. Jiménez; C. Lagunas

In vitro suceptibilities of clinical yeast isolates to the new antifungal eberconazole compared with their susceptibilities to clotrimazole and ketoconazole

J.M. Torres-Rodríguez, R. Méndez, O. López-Jodra, Y. Morera, M. Espasa, T. Jiménez, C. Lagunas

Department of Genetics and Microbiology

Research output: Contribution to journal › Article › Research

Original language	English
Pages (from-to)	1258-1259
Journal	Antimicrob. Agents Chemother.
Volume	43
Issue number	5
Publication status	Published - 1 May 1999

Cite this

@article{573847a63dba48ef8696318de8871432,

title = "In vitro suceptibilities of clinical yeast isolates to the new antifungal eberconazole compared with their susceptibilities to clotrimazole and ketoconazole",

author = "J.M. Torres-Rodr{\'i}guez and R. M{\'e}ndez and O. L{\'o}pez-Jodra and Y. Morera and M. Espasa and T. Jim{\'e}nez and C. Lagunas",

year = "1999",

month = may,

day = "1",

language = "English",

volume = "43",

pages = "1258--1259",

number = "5",

}

In vitro suceptibilities of clinical yeast isolates to the new antifungal eberconazole compared with their susceptibilities to clotrimazole and ketoconazole. / Torres-Rodríguez, J.M.; Méndez, R.; López-Jodra, O.; Morera, Y.; Espasa, M.; Jiménez, T.; Lagunas, C.

In: Antimicrob. Agents Chemother., Vol. 43, No. 5, 01.05.1999, p. 1258-1259.

Research output: Contribution to journal › Article › Research

TY - JOUR

T1 - In vitro suceptibilities of clinical yeast isolates to the new antifungal eberconazole compared with their susceptibilities to clotrimazole and ketoconazole

AU - Torres-Rodríguez, J.M.

AU - Méndez, R.

AU - López-Jodra, O.

AU - Morera, Y.

AU - Espasa, M.

AU - Jiménez, T.

AU - Lagunas, C.

PY - 1999/5/1

Y1 - 1999/5/1

M3 - Article

VL - 43

SP - 1258

EP - 1259

IS - 5

ER -